| NCT Number | NCT06830304 |
| Lead Sponsor | Chongqing University Cancer Hospital |
| Conditions | Screening Compliance |
| Enrollment | 15,000 participants |
| Start Date | 2024-04-16 |
| Primary Completion | 2025-03-30 (estimated) |
| Study Completion | 2025-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-02-17 |